These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Castle W; Fuller R; Hall J; Palmer J BMJ; 1993 Apr; 306(6884):1034-7. PubMed ID: 8098238 [TBL] [Abstract][Full Text] [Related]
23. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. Lipworth BJ; Jackson C Am J Respir Crit Care Med; 1999 Dec; 160(6):2125-6. PubMed ID: 10755831 [No Abstract] [Full Text] [Related]
24. Bronchodilator treatment in asthma. Fuller RW; Castle WM; Palmer JB; Hall JR BMJ; 1993 Sep; 307(6905):683. PubMed ID: 8292148 [No Abstract] [Full Text] [Related]
25. Safety Study of Salmeterol in Asthma in Adults. Weinberger M N Engl J Med; 2016 Sep; 375(11):1097-8. PubMed ID: 27626534 [No Abstract] [Full Text] [Related]
26. Safety Study of Salmeterol in Asthma in Adults. Hasegawa T; Uno H; Wei LJ N Engl J Med; 2016 Sep; 375(11):1097. PubMed ID: 27626533 [No Abstract] [Full Text] [Related]
27. Safety Study of Salmeterol in Asthma in Adults. Wilsdon T; Kichenadasse G; Rowland A N Engl J Med; 2016 Sep; 375(11):1096-7. PubMed ID: 27626532 [No Abstract] [Full Text] [Related]
28. Safety Study of Salmeterol in Asthma in Adults. Stempel DA; Yeakey AM; Pascoe SJ N Engl J Med; 2016 Sep; 375(11):1098. PubMed ID: 27626531 [No Abstract] [Full Text] [Related]
29. Bronchodilator treatment in asthma. Sears MR; Taylor DR BMJ; 1993 Aug; 307(6901):446. PubMed ID: 8374471 [No Abstract] [Full Text] [Related]
30. Salmeterol and formoterol: asthma aggravation. Use should be restricted. Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580 [No Abstract] [Full Text] [Related]
31. Salmeterol response and beta(2)-adrenergic receptor genotype. Jackson C; Lipworth B J Allergy Clin Immunol; 2007 Jul; 120(1):217-8; author reply 219-20. PubMed ID: 17399780 [No Abstract] [Full Text] [Related]
32. Inhaled salmeterol. Rubin ID East Afr Med J; 1994 Aug; 71(8):547. PubMed ID: 7867552 [No Abstract] [Full Text] [Related]
33. The pathobiologic implications for treatment. Old and new strategies in the treatment of chronic asthma. Horiuchi T; Castro M Clin Chest Med; 2000 Jun; 21(2):381-95, x. PubMed ID: 10907595 [TBL] [Abstract][Full Text] [Related]
34. Salmeterol for the treatment of asthma. Weinberger M Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921 [No Abstract] [Full Text] [Related]
35. beta-adrenergic receptor genotype and response to salmeterol. Wechsler ME; Israel E J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776 [No Abstract] [Full Text] [Related]
36. Beta2 déjà vu. O'Byrne PM; Adelroth E Chest; 2006 Jan; 129(1):3-5. PubMed ID: 16424402 [No Abstract] [Full Text] [Related]
37. Salmeterol. Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139 [No Abstract] [Full Text] [Related]
38. Long acting beta 2 agonists and the risk of life threatening asthma. Ernst P Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513 [No Abstract] [Full Text] [Related]
39. [Serevent in the treatment of moderate bronchial asthma]. Panghea P; Voicu G; Filip G; Arghir O; Floca L; Acasandri E; Mihai D Pneumoftiziologia; 1996; 45(3-4):145-8. PubMed ID: 9221040 [TBL] [Abstract][Full Text] [Related]
40. [Pharmacy clinics. Drug of the month. Salmeterol (Serevent)]. Scheen AJ Rev Med Liege; 1995 Jun; 50(6):270-1. PubMed ID: 7618007 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]